ARCHIVES

Chemoprevention Concept Approved By DCPC Bard Uses Biological Markers To Assess Risk Modulation

This article is from The Cancer Letter archive.

Vol. 11 No. 37 | September 27, 1985

Download PDF Visit The Full Archive

Related Articles

NCCS Networker Volume 5 Issue 4, Fall 1991

September 13, 1991

Regulatory Agencies: FDA Proposes “Treatment IDE” Funding Opportunities:

February 7, 1997

Wistar Investigators Report Oncogene Relation to Burkitt’s

November 26, 1982

Funding Opportunities: Career Development Award In Leukemia

July 23, 1999

NCI to Advise Women in 40s o Ask Doctor About Mammography, End Routine Screening

September 24, 1993

FDA Approves Lilly’s Alimta For Metastatic NSCLC

August 27, 2004